Acquisition of an in vitro diagnostic device for the definition of HLA class I A, B and C genotypes and class II DRB1/3/4/5, DQA1/B1 and DPA1/B1 in allelic resolution for IPST-IP during the period from 2023 to 2025.
Acquisition of an in vitro diagnostic device for the definition of HLA class I A, B and C genotypes and class II DRB1/3/4/5, DQA1/B1 and DPA1/B1 in allelic resolution for IPST-IP during the period from 2023 to 2025.